Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 321

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

European guidelines for sclerotherapy in chronic venous disorders

Rabe, E, Breu, FX, Cavezzi, A, Smith, P Coleridge, Frullini, A, Gillet, JL, Guex, JJ, Hamel-Desnos, C, Kern, P, Partsch, B, Ramelet, AA, Tessari, L, Pannier, F, for the Guideline Group·2014·Phlebology: The Journal of Venous Disease

Abstract

Aim: Sclerotherapy is the targeted chemical ablation of varicose veins by intravenous injection of a liquid or foamed sclerosing drug. The treated veins may be intradermal, subcutaneous, and/or transfascial as well as superficial and deep in venous malformations. The aim of this guideline is to give evidence-based recommendations for liquid and foam sclerotherapy. Methods: This guideline was drafted on behalf of 23 European Phlebological Societies during a Guideline Conference on 7–10 May 2012 in Mainz. The conference was organized by the German Society of Phlebology. These guidelines review the present state of knowledge as reflected in published medical literature. The regulatory situation of sclerosant drugs differs from country to country but this has not been considered in this document. The recommendations of this guideline are graded according to the American College of Chest Physicians Task Force recommendations on Grading Strength of Recommendations and Quality of Evidence in Clinical Guidelines. Results: This guideline focuses on the two sclerosing drugs which are licensed in the majority of the European countries, polidocanol and sodium tetradecyl sulphate. Other sclerosants are not discussed in detail. The guideline gives recommendations concerning indications, contraindications, side-effects, concentrations, volumes, technique and efficacy of liquid and foam sclerotherapy of varicose veins and venous malformations.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/0268355513483280

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 26 references

Cited by

See all 321

Metadata

Authors
Rabe, E., Breu, F., Cavezzi, A., Smith, P. C., Frullini, A., Gillet, J., Guex, J., Hamel-Desnos, C., Kern, P., Partsch, B., Ramelet, A., Tessari, L., Pannier, F., & for the Guideline Group
Venue
Phlebology: The Journal of Venous Disease
Published
2013-05-06
Volume
29
Issue
6
Pages
338-354
ISSN
  • 0268-3555 (ISSN-L)
  • 1758-1125
OpenAlex
W2115650583
Cited by
321
References
26
FWCI
17.36
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: European guidelines for sclerotherapy in chronic venous disorders. https://app.cochat.ai/papers/10.1177/0268355513483280
The paper
Rabe, E., Breu, F., Cavezzi, A., Smith, P. C., Frullini, A., Gillet, J., Guex, J., Hamel-Desnos, C., Kern, P., Partsch, B., Ramelet, A., Tessari, L., Pannier, F., & for the Guideline Group. (2014). European guidelines for sclerotherapy in chronic venous disorders. Phlebology: The Journal of Venous Disease. https://doi.org/10.1177/0268355513483280

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.